[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100497733":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":45,"responsibleParty":137,"collaborators":26,"id":141,"slug":142,"hasResults":143,"nctId":144,"briefTitle":145,"officialTitle":146,"acronym":147,"eligibilityCriteria":148,"healthyVolunteers":143,"sex":149,"minAge":150,"maxAge":151,"enrollmentInfo":152,"targetDuration":26,"studyType":155,"phases":156,"briefSummary":158,"conditions":159,"keywords":163,"overallStatus":48,"whyStopped":26,"lastUpdateSubmitDate":165,"lastUpdatePostDateStruct":166,"startDateStruct":169,"completionDateStruct":171,"leadSponsor":173,"locationsCount":174},{"fullName":5,"class":6},"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental branch","EXPERIMENTAL","Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center for 3 days, followed of oral amoxicillin-clavulanic acid (40mg\u002Fkg in 3 times\u002Fday; maximum dose 3g\u002Fday) for two more days at home",[13],"Drug: Oral amoxicillin-clavulanic acid (40mg\u002Fkg in 3 times\u002Fday; maximum dose 3g\u002Fday)",{"label":15,"type":16,"description":17,"interventionNames":18},"Control branch","ACTIVE_COMPARATOR","Inpatient postoperative intravenous treatment according to the protocol established in each center, lasting 5 days",[19],"Drug: Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Oral amoxicillin-clavulanic acid (40mg\u002Fkg in 3 times\u002Fday; maximum dose 3g\u002Fday)","Inpatient postoperative intravenous treatment according to the established protocol in each center for 3 days, followed of oral amoxicillin-clavulanic acid (40mg\u002Fkg in 3 times\u002Fday; maximum dose 3g\u002Fday) for two more days at home",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center","Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center for 5 days",[15],[32],{"name":33,"affiliation":34,"role":35},"Maria Jose Martinez-Zapata, MD, PhD","Institut de Recerca Sant Pau","STUDY_CHAIR",[37,41],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},"CONTACT","+34935537901","mmartinezz@santpau.cat",{"name":42,"role":38,"phone":43,"phoneExt":26,"email":44},"Carlos Leganés Villanueva, MD","+34935537634","cleganes@santpau.cat",[46,61,74,84,97,111,124],{"facility":47,"status":48,"city":49,"state":49,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Hospital de la Santa Creu i Sant Pau","RECRUITING","Barcelona","Spain","ES",{"type":53,"coordinates":54},"Point",[55,56],2.15899,41.38879,{"lat":56,"lon":55},[59],{"name":60,"role":38,"phone":43,"phoneExt":26,"email":44},"Carlos Leganes, MD",{"facility":62,"status":48,"city":63,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Hospital Germans Trias i Pujol","Badalona",{"type":53,"coordinates":65},[66,67],2.24741,41.45004,{"lat":67,"lon":66},[70],{"name":71,"role":38,"phone":72,"phoneExt":26,"email":73},"Alba Martin Lluis, MD, PhD","+34 934651200","martin.cirped@gmail.com",{"facility":75,"status":48,"city":49,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":76,"geoPoint":78,"contacts":79},"Hospital del Mar",{"type":53,"coordinates":77},[55,56],{"lat":56,"lon":55},[80],{"name":81,"role":38,"phone":82,"phoneExt":26,"email":83},"Estela Membrilla Fernandez, MD, PhD","+34 932483207","emembrilla@psmar.cat",{"facility":85,"status":48,"city":86,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Hospital Sant Joan de Deu","Esplugues de Llobregat",{"type":53,"coordinates":88},[89,90],2.08809,41.37732,{"lat":90,"lon":89},[93],{"name":94,"role":38,"phone":95,"phoneExt":26,"email":96},"Pedro Palafon Belver, MD, PhD","+34 932532100","pedro.palafon@sjd.es",{"facility":98,"status":48,"city":99,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"Hospital Universitario Dr. Josep Trueta","Girona",{"type":53,"coordinates":101},[102,103],2.82493,41.98311,{"lat":103,"lon":102},[106],{"name":107,"role":38,"phone":108,"phoneExt":109,"email":110},"Enrique Antonio Bordon Cabrera, MD, PhD","+34 972940200","2292","eabordon.girona.ics@gencat.cat",{"facility":112,"status":48,"city":113,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Complejo Universitario Hospitalario de Santiago de Compostela","Santiago de Compostela",{"type":53,"coordinates":115},[116,117],-8.54569,42.88052,{"lat":117,"lon":116},[120],{"name":121,"role":38,"phone":122,"phoneExt":26,"email":123},"Lorena Miguez Fortes, MD, PhD","+34 981950000","lorena.maria.miguez.cortes@sergas.es",{"facility":125,"status":48,"city":126,"state":26,"zip":26,"country":50,"countryCode":51,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"Hospital Joan XXIII","Tarragona",{"type":53,"coordinates":128},[129,130],1.24544,41.11905,{"lat":130,"lon":129},[133],{"name":134,"role":38,"phone":135,"phoneExt":26,"email":136},"Carlos Pueyo Gil, MD, PhD","+34 977295800","pueyogil@gmail.com",{"type":138,"investigatorFullName":139,"investigatorTitle":140,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Mª José Martínez Zapata","Main research coordinator","100497733","phase-4-fast-track-therapeutic-model-in-acute-complicated-appendicitis-in-pediatrics-100497733",false,"NCT05761080","Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics","Evaluation of a Therapeutic Strategy to Shorten Hospital Stay in Complicated Pediatric Appendicitis: A Randomized, Parallel, Multicenter, Open-Label Clinical Trial","FTAA","Inclusion criteria:\n\n* Ages 2 to 17 years. Intraoperative diagnosis of complicated appendicitis. Laparoscopic appendectomy. Agreement to participate in the study with signed informed consent.\n\nExclusion criteria:\n\n* Peritonitis with sepsis criteria. Catarrhal or phlegmonous appendicitis. History of cystic fibrosis, Crohn's disease, or transplant that may interfere with the usual postoperative course of laparoscopic appendectomy.\n\nContraindication to the administration of amoxicillin-clavulanic acid. Refusal to participate in the study by parents\u002Flegal guardians.","ALL","2 Years","17 Years",{"count":153,"type":154},772,"ESTIMATED","INTERVENTIONAL",[157],"PHASE4","To evaluate whether a postoperative therapeutic strategy, Fast Track, aimed at shortening hospital stay in pediatric patients undergoing laparoscopic appendectomy for complicated acute appendicitis, yields outcomes that are not inferior to the standard therapeutic model in terms of the combined variable of adverse events within 30 days postoperatively (including postoperative abdominal abscess, peritonitis, surgical wound complications, reintervention, sepsis, or death).",[160,161,162],"Laparoscopic Appendectomy","Complicated Appendicitis","Periappendicular Abscess",[164],"Complicated appendicitis","2026-03-19",{"date":167,"type":168},"2026-03-20","ACTUAL",{"date":170,"type":168},"2021-04-22",{"date":172,"type":154},"2027-12",{"name":5,"class":6},7]